VivoSim Labs, Inc. Financing Cash Flow
VivoSim Labs, Inc. (VIVS) reported Financing Cash Flow of -$118.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-12
- VivoSim Labs, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$118.00K, a 107.01% decline year-over-year.
- VivoSim Labs, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $2.88M, a 9.58% decline year-over-year.
- VivoSim Labs, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$118.00K.
- VivoSim Labs, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $0.00.
- VivoSim Labs, Inc. net cash provided by (used in) financing activities for fiscal 2026 was $4.45M, a 49.76% decline from fiscal 2025.
- VivoSim Labs, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $8.85M, a 515.66% increase from fiscal 2024.
- VivoSim Labs, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $1.44M.
- VivoSim Labs, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 21 month | Net Cash Provided by (Used in) Financing Activities 24 month | Net Cash Provided by (Used in) Financing Activities 59 month | Net Cash Provided by (Used in) Financing Activities 62 month | Net Cash Provided by (Used in) Financing Activities 65 month | Net Cash Provided by (Used in) Financing Activities 68 month | Net Cash Provided by (Used in) Financing Activities 71 month | Net Cash Provided by (Used in) Financing Activities 74 month | Net Cash Provided by (Used in) Financing Activities 77 month | Net Cash Provided by (Used in) Financing Activities 80 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$118.00K 10-Q · filed 2026-08-12 | $2.76M derived: sum of 2 quarters · filed 2026-08-12 | $2.64M derived: sum of 3 quarters · filed 2026-08-12 | $2.64M derived: sum of 4 quarters · filed 2026-08-12 | |||||||||||
| 2026-03-31 | $2.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $2.76M derived: sum of 2 quarters · filed 2026-07-14 | $2.76M derived: sum of 3 quarters · filed 2026-07-14 | $4.45M 10-K · filed 2026-07-14 | |||||||||||
| 2025-12-31 | -$118.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-11 | -$118.00K derived: sum of 2 quarters · filed 2026-02-11 | $1.56M 10-Q · filed 2026-02-11 | $4.75M derived: sum of 4 quarters · filed 2026-08-12 | |||||||||||
| 2025-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | $1.68M 10-Q · filed 2025-11-06 | $4.87M derived: sum of 3 quarters · filed 2026-08-12 | $4.65M derived: sum of 4 quarters · filed 2026-08-12 | |||||||||||
| 2025-06-30 | $1.68M 10-Q · filed 2026-08-12 | $4.87M derived: sum of 2 quarters · filed 2026-08-12 | $4.65M derived: sum of 3 quarters · filed 2026-08-12 | $4.28M derived: sum of 4 quarters · filed 2026-08-12 | |||||||||||
| 2025-03-31 | $3.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $2.97M derived: sum of 2 quarters · filed 2026-07-14 | $2.60M derived: sum of 3 quarters · filed 2026-07-14 | $8.85M 10-K · filed 2026-07-14 | |||||||||||
| 2024-12-31 | -$216.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-11 | -$587.00K derived: sum of 2 quarters · filed 2026-02-11 | $5.66M 10-Q · filed 2026-02-11 | $5.93M derived: sum of 4 quarters · filed 2026-02-11 | |||||||||||
| 2024-09-30 | -$371.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | $5.88M 10-Q · filed 2025-11-06 | $6.14M derived: sum of 3 quarters · filed 2025-11-06 | $7.32M derived: sum of 4 quarters · filed 2025-11-06 | |||||||||||
| 2024-06-30 | $6.25M 10-Q · filed 2025-08-12 | $6.51M derived: sum of 2 quarters · filed 2025-08-12 | $7.69M derived: sum of 3 quarters · filed 2025-08-12 | $7.69M derived: sum of 4 quarters · filed 2025-08-12 | |||||||||||
| 2024-03-31 | $264.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-05 | $1.44M derived: sum of 2 quarters · filed 2025-06-05 | $1.44M derived: sum of 3 quarters · filed 2025-06-05 | $1.44M 10-K · filed 2025-06-05 | |||||||||||
| 2023-12-31 | $1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-19 | $1.17M derived: sum of 2 quarters · filed 2025-02-19 | $1.17M 10-Q · filed 2025-02-19 | $1.17M derived: sum of 4 quarters · filed 2025-02-19 | |||||||||||
| 2023-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-08 | $0.00 10-Q · filed 2024-11-08 | $0.00 derived: sum of 3 quarters · filed 2024-11-08 | $0.00 derived: sum of 4 quarters · filed 2024-11-08 | |||||||||||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-05 | $0.00 derived: sum of 2 quarters · filed 2024-08-05 | $0.00 derived: sum of 3 quarters · filed 2024-08-05 | $0.00 derived: sum of 4 quarters · filed 2024-08-05 | |||||||||||
| 2023-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-31 | $0.00 derived: sum of 2 quarters · filed 2024-05-31 | $0.00 derived: sum of 3 quarters · filed 2024-05-31 | $0.00 10-K · filed 2024-05-31 | |||||||||||
| 2022-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08 | $0.00 derived: sum of 2 quarters · filed 2024-02-08 | $0.00 10-Q · filed 2024-02-08 | $0.00 derived: sum of 4 quarters · filed 2024-02-08 | |||||||||||
| 2022-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | $0.00 derived: sum of 3 quarters · filed 2023-11-09 | -$1.00K derived: sum of 4 quarters · filed 2023-11-09 | |||||||||||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-10 | $0.00 derived: sum of 2 quarters · filed 2023-08-10 | -$1.00K derived: sum of 3 quarters · filed 2023-08-10 | -$46.00K derived: sum of 4 quarters · filed 2023-08-10 | |||||||||||
| 2022-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-14 | -$1.00K derived: sum of 2 quarters · filed 2023-07-14 | -$46.00K derived: sum of 3 quarters · filed 2023-07-14 | $205.00K 10-K · filed 2023-07-14 | |||||||||||
| 2021-12-31 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-09 | -$46.00K derived: sum of 2 quarters · filed 2023-02-09 | $205.00K 10-Q · filed 2023-02-09 | $20.96M derived: sum of 4 quarters · filed 2023-02-09 | |||||||||||
| 2021-09-30 | -$45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-10 | $206.00K 10-Q · filed 2022-11-10 | $20.96M derived: sum of 3 quarters · filed 2022-11-10 | $24.03M derived: sum of 4 quarters · filed 2022-11-10 | |||||||||||
| 2021-06-30 | $251.00K 10-Q · filed 2022-08-11 | $21.00M derived: sum of 2 quarters · filed 2022-08-11 | $24.07M derived: sum of 3 quarters · filed 2022-08-11 | $24.09M derived: sum of 4 quarters · filed 2022-08-11 | |||||||||||
| 2021-03-31 | $20.75M derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-10 | $23.82M derived: sum of 2 quarters · filed 2022-06-10 | $23.84M derived: sum of 3 quarters · filed 2022-06-10 | $23.84M 10-K · filed 2022-06-10 | |||||||||||
| 2020-12-31 | $3.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-14 | $3.08M derived: sum of 2 quarters · filed 2022-02-14 | $3.08M 10-Q · filed 2022-02-14 | $3.08M derived: sum of 4 quarters · filed 2022-02-14 | |||||||||||
| 2020-09-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-08 | $11.00K 10-Q · filed 2021-11-08 | $11.00K derived: sum of 3 quarters · filed 2021-11-08 | $10.00K derived: sum of 4 quarters · filed 2021-11-08 | |||||||||||
| 2020-06-30 | -$1.00K 10-Q · filed 2021-08-06 | -$1.00K derived: sum of 2 quarters · filed 2021-08-06 | -$2.00K derived: sum of 3 quarters · filed 2021-08-06 | -$10.00K derived: sum of 4 quarters · filed 2021-08-06 | |||||||||||
| 2020-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-15 | -$1.00K derived: sum of 2 quarters · filed 2021-06-15 | -$9.00K derived: sum of 3 quarters · filed 2021-06-15 | $4.93M 10-K · filed 2021-06-15 | |||||||||||
| 2019-12-31 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-08 | -$9.00K derived: sum of 2 quarters · filed 2021-02-08 | $4.93M 10-Q · filed 2021-02-08 | $11.26M derived: sum of 4 quarters · filed 2021-02-08 | |||||||||||
| 2019-09-30 | -$8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-05 | $4.94M 10-Q · filed 2020-11-05 | $11.26M derived: sum of 3 quarters · filed 2020-11-05 | $13.11M derived: sum of 4 quarters · filed 2020-11-05 | |||||||||||
| 2019-06-30 | $4.94M 10-Q · filed 2020-08-10 | $11.27M derived: sum of 2 quarters · filed 2020-08-10 | $13.11M derived: sum of 3 quarters · filed 2020-08-10 | $15.19M derived: sum of 4 quarters · filed 2020-08-10 | |||||||||||
| 2019-03-31 | $6.32M derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-28 | $8.17M derived: sum of 2 quarters · filed 2020-05-28 | $10.25M derived: sum of 3 quarters · filed 2020-05-28 | $13.15M 10-K · filed 2020-05-28 | |||||||||||
| 2018-12-31 | $1.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10 | $3.92M derived: sum of 2 quarters · filed 2020-02-10 | $6.83M 10-Q · filed 2020-02-10 | $8.95M derived: sum of 4 quarters · filed 2020-02-10 | |||||||||||
| 2018-09-30 | $2.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-07 | $4.98M 10-Q · filed 2019-11-07 | $7.10M derived: sum of 3 quarters · filed 2019-11-07 | $10.19M derived: sum of 4 quarters · filed 2019-11-07 | |||||||||||
| 2018-06-30 | $2.91M 10-Q · filed 2019-08-08 | $5.03M derived: sum of 2 quarters · filed 2019-08-08 | $8.11M derived: sum of 3 quarters · filed 2019-08-08 | $10.06M derived: sum of 4 quarters · filed 2019-08-08 | |||||||||||
| 2018-03-31 | $2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-03 | $5.20M derived: sum of 2 quarters · filed 2019-06-03 | $7.16M derived: sum of 3 quarters · filed 2019-06-03 | $10.11M 10-K · filed 2019-06-03 | |||||||||||
| 2017-12-31 | $3.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-07 | $5.04M derived: sum of 2 quarters · filed 2019-02-07 | $8.00M 10-Q · filed 2019-02-07 | ||||||||||||
| 2017-09-30 | $1.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-08 | $4.91M 10-Q · filed 2018-11-08 | |||||||||||||
| 2017-06-30 | $2.96M 10-Q · filed 2018-08-09 | ||||||||||||||
| 2013-12-31 | $387.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-06 | $44.50M derived: sum of 2 quarters · filed 2014-02-06 | $44.50M 10-Q · filed 2014-02-06 | $48.22M derived: sum of 4 quarters · filed 2014-02-06 | $77.03M 10-Q · filed 2014-02-06 | ||||||||||
| 2013-09-30 | $44.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-08 | $44.11M 10-Q · filed 2013-11-08 | $47.83M derived: sum of 3 quarters · filed 2013-11-08 | $57.05M derived: sum of 4 quarters · filed 2014-02-06 | $76.64M 10-Q · filed 2013-11-08 | ||||||||||
| 2013-06-30 | -$3.00K 10-Q · filed 2013-08-09 | $3.72M derived: sum of 2 quarters · filed 2013-08-09 | $12.94M derived: sum of 3 quarters · filed 2014-02-06 | $14.62M derived: sum of 4 quarters · filed 2014-02-06 | $32.53M 10-Q · filed 2013-08-09 | ||||||||||
| 2013-03-31 | $3.72M 10-KT · filed 2013-05-24 | $12.94M derived: sum of 2 quarters · filed 2014-02-06 | $14.63M derived: sum of 3 quarters · filed 2014-02-06 | $14.72M derived: sum of 4 quarters · filed 2014-02-06 | $32.53M 10-KT · filed 2013-05-24 | ||||||||||
| 2012-12-31 | $9.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-06 | $10.90M derived: sum of 2 quarters · filed 2014-02-06 | $11.00M 10-Q · filed 2014-02-06 | $24.61M 10-KT · filed 2013-05-24 | $28.81M 10-K · filed 2013-03-15 | ||||||||||
| 2012-09-30 | $1.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-08 | $1.78M 10-Q · filed 2013-11-08 | $15.39M 10-Q · filed 2012-11-14 | $15.40M derived: sum of 4 quarters · filed 2013-11-08 | $19.59M 10-Q · filed 2012-11-14 | ||||||||||
| 2012-06-30 | $99.00K 10-Q · filed 2013-08-09 | $13.71M 10-Q · filed 2012-08-14 | $13.72M derived: sum of 3 quarters · filed 2013-08-09 | $13.72M derived: sum of 4 quarters · filed 2013-08-09 | $17.90M 10-Q · filed 2012-08-14 | ||||||||||
| 2012-03-31 | $13.61M 10-KT · filed 2013-05-24 | $13.61M 10-Q · filed 2012-05-15 | $13.62M derived: sum of 2 quarters · filed 2013-05-24 | $13.62M derived: sum of 3 quarters · filed 2013-05-24 | $13.91M derived: sum of 4 quarters · filed 2013-05-24 | $17.80M 10-Q · filed 2012-05-15 | |||||||||
| 2011-12-31 | $9.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-01-17 | $9.50K 10-Q · filed 2012-01-17 | $292.69K derived: sum of 3 quarters · filed 2012-08-14 | $2.08M 10-KT · filed 2013-05-24 | $180.43K 10-Q · filed 2012-01-17 | ||||||||||
| 2011-09-30 | $0.00 10-Q · filed 2011-10-31 | $283.19K derived: sum of 2 quarters · filed 2012-08-14 | $811.52K 10-Q · filed 2012-11-14 | $417.29K derived: sum of 4 quarters · filed 2012-08-14 | $170.93K 10-Q · filed 2011-10-31 | ||||||||||
| 2011-06-30 | $283.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $417.29K 10-Q · filed 2012-08-14 | $417.29K derived: sum of 3 quarters · filed 2012-08-14 | $417.36K derived: sum of 4 quarters · filed 2012-08-14 | |||||||||||
| 2011-03-31 | $134.10K 10-Q · filed 2012-05-15 | $134.10K derived: sum of 2 quarters · filed 2012-05-15 | $134.17K derived: sum of 3 quarters · filed 2012-05-15 | ||||||||||||
| 2010-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-01-17 | $75.00 10-Q · filed 2012-01-17 | $1.02M 10-KT · filed 2013-05-24 | ||||||||||||
| 2010-09-30 | $75.00 10-Q · filed 2011-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |